Keywords
Interleukin-6
Coronary Artery Bypass
Biomarkers
Inflammatory Process
Systematic Review
Categories
How to Cite
Abstract
Atrial fibrillation (AF) progresses after coronary bypass grafting in 11–40% of patients. Plasma biomarkers such as interleukin 6 (IL-6) can assess the risk of AF development. We performed a systematic review using as sources: PubMed, LILACS, and Cochrane Library databases were investigated using Boolean operators and MeSH terms (Medical Subject Headings Terms) “Atrial Fibrillation AND Interleukin AND Biomarkers”. As the following eligibility criteria: observational studies, studies with coronary artery bypass grafting with plasma levels of IL-6 recorded after the screening, 11 articles were selected. Three studies met the inclusion and exclusion criteria. Results: IL-6 levels in AF group - Ishida et al. reported the plasma levels of IL-6 during the post-operative period as 360 ± 143 pg/mL, while Pretorius et al. reported it to be 380.6 ± 151.1 pg/mL. Lastly, Ziabakhsh-Tabari et al. reported a post-operative plasma IL-6 level of 38.2 ± 32 pg/mL. It is considered that new studies about the object are necessary, and these studies should be more standardized. Preferably, it would be important for the daily measurement of IL-6 and its correlation with AF development for statistical analysis to set the best time for sample collection and cut-off value.
References
Habibollahi P, Jam SH, Vahdati SS, Baghi HM, Amiri H. Amiodaron in atrial fibrillation: post coronary artery bypass graft. World J Emerg Med. 2016;7(4):250. https://doi.org/10.5847/wjem.j.1920-8642.2016.04.002
Maisel WH, Rawn JD, Stevenson WG. Atrial fibrillation after cardiac surgery. Ann Intern Med. 2001;135(12):1061-1073. https://doi.org/10.7326/0003-4819-135-12-200112180-00010
Prestes J, Donatto FF, Dias R, Frollini AB, Cavaglieri CR. Papel da Interleucina-6 como um sinalizador em diferentes tecidos durante o exercício físico. Fitness Perform J. 2006;5(6): 348-353. [Accessed 2021 Febr 13]. Available From: https://dialnet.unirioja.es/servlet/articulo?codigo=2949762
Hijazi Z, Oldgren J, Siegbahn A, Granger CB, Wallentin L. Biomarkers in atrial fibrillation: a clinical review. Eur Heart J. 2013;34(20): 1475-1480. https://doi.org/10.1093/eurheartj/eht024
Pedersen BK, Febbraio M. Muscle-derived interleukin-6—a possible link between skeletal muscle, adipose tissue, liver, and brain. Brain Behav Immun. 2005;19(5): 371-376. https://doi.org/10.1016/j.bbi.2005.04.008
Pedersen BK, Toft AD. Effects of exercise on lymphocytes and cytokines. Br J Sports Med. 2000; 34(4):246-251. https://doi.org/10.1136/bjsm.34.4.246
Gomes MAM, Neto NCM, Bispo IGA. Interleucina-6, moléculas de adesão intercelular-1 e microalbuminúria na avaliação da lesão endotelial: revisão de literatura. Rev SOCERJ. 2009;22(6). 398-403. [Accessed 2021 Febr 13]. Available From: http://sociedades.cardiol.br/socerj/revista/2009_06/a2009_v22_n06_07atumgomes.pdf
Souza JRM, Oliveira RT, Blotta MHS, Coelho OR. Níveis séricos de interleucina-6 (IL-6), interleucina-18 (IL-18) e proteína C reativa (PCR) na síndrome coronariana aguda sem supradesnivelamento do ST em pacientes com diabete tipo 2. Arq Bras Cardiol. 2008; 90(2): 94-99. https://doi.org/10.1590/S0066-782X2008000200004
Tonet AC, Karnikowski M, Moraes CF, Gomes L, Karnikowski MGO, Córdova C, et al. Association between the-174 G/C promoter polymorphism of the interleukin-6 gene and cardiovascular disease risk factors in Brazilian older women. Braz J Med Biol Res.2008 Jan;41(1):47-53. https://doi.org/10.1590/s0100-879x2006005000190
Canbaz S, Erbas H, Huseyin S, Duran E. The role of inflammation in atrial fibrillation following open heart surgery. J Int Med Res. 2008;36(5): 1070-1076. https://doi.org/10.1177/147323000803600526
Czerny M, Baumer H, Kilo J. Lassnigg A, Hamwi A, Vukovich T. Inflammatory response and myocardial injury following coronary artery bypass grafting with or without cardiopulmonary bypass. Eur J Cardiothorac Surg. 2000;17(6):737-742. https://doi.org/10.1016/s1010-7940(00)00420-6
Girerd N, Pibarot P, Fournier D, Daleau P, Voisine P, O'Hara G. Middle-aged men with increased waist circumference and elevated C-reactive protein level are at higher risk for postoperative atrial fibrillation following coronary artery bypass grafting surgery. Eur Heart J. 2009;30(10):1270-1278. https://doi.org/10.1093/eurheartj/ehp091
Ishida K, Kimura F, Imamaki M, Ishida A, Shimura H, Kohno H. Relation of inflammatory cytokines to atrial fibrillation after off-pump coronary artery bypass grafting. Eur. J Cardiothorac Surg. 2006;29(4):501-505. https://doi.org/10.1016/j.ejcts.2005.12.028
Kaireviciute D, Lip GYH, Balakrishnan B, Uzdavinys G, Norkunas G, Kalinauskas G. Intracardiac expression of markers of endothelial damage/dysfunction, inflammation, thrombosis, and tissue remodeling, and the development of postoperative atrial fibrillation. J Thromb Haemost. 2011;9(12): 2345-2352. https://doi.org/10.1111/j.1538-7836.2011.04523.x
Kaireviciute D, Blann AD, Balakrishnan B, Uzdavinys G, Norkunas G, Kalinauskas G. Characterisation and validity of inflammatory biomarkers in the prediction of post-operative atrial fibrillation in coronary artery disease patients. Thromb.Haemost. 2010; 104(1): 122-127. https://doi.org/10.1111/j.1538-7836.2011.04523.x
Kourliouros A, Karastergiou KJ. NowellGukop P, Hosseini TM, Valencia O. Protective effect of epicardial adiponectin on atrial fibrillation following cardiac surgery. Eur. J Cardiothorac Surg. 2011; 39(2): 228-232. https://doi.org/10.1016/j.ejcts.2010.05.006
Pierri MD, Crescenzi G, Zingaro C, D'Alfonso A, Capestro F. ScoccoV, et al. Prevention of atrial fibrillation and inflammatory response after on-pump coronary artery bypass using different statin dosages: a randomized, controlled trial. Gen Thorac Cardiovasc Surg. 2016;64(7): 395-402. https://doi.org/10.1007/s11748-016-0647-y
Pretorius M, Donahue BS, Yu C, Greelish JP, Roden DM, Brown NJ. Plasminogen activator inhibitor-1 as a predictor of postoperative atrial fibrillation after cardiopulmonary bypass. Circulation. 2007;116(11 Suppl):I1-I7.
https://doi.org/10.1161/CIRCULATIONAHA.106.677906
Ziabakhsh-Tabari S. Can perioperative C-reactive protein and interleukin-6 levels predict atrial fibrillation after coronary artery bypass surgery? Saudi Med J. 2008; 29(10):1429-1431.
Karth GD, Buberl A, Nikfardjam MMeyer B, Wollenek G, Grimm M. Role of amiodarone on the systemic inflammatory response induced by cardiac surgery: proinflammatory actions. Can J Anesth. 2007; 54(4), 262‐268. https://doi.org/10.1007/BF03022770
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann. Intern.Med. 2009; 151(4), 264-269. https://doi.org/10.1371/journal.pmed.1000097
Pires LA, Wagshal AB, Lancey R, Huang SKS,Arrhythmias and conduction disturbances after coronary artery bypass graft surgery: epidemiology, management, and prognosis. Am. Heart J.1995;129(4):799-808. https://doi.org/10.1016/0002-8703(95)90332-1
European Heart Rhythm Association; Heart Rhythm Society; Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation) . J Am Coll Cardiol .2006 Aug 15;48(4):854-906. https://doi.org/10.1016/j.jacc.2006.07.009
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2021 da Mata RG et al.
